Fragment-Based Screening of the Bromodomain of ATAD2

Mary J. Harner, Brian A. Chauder, Jason Phan, Stephen W. Fesik

Journal of Medicinal Chemistry · 2014 · 82 citations · 16 references

DOIFull text

Open access

Concepts

Abstract

Cellular and genetic evidence suggest that inhibition of ATAD2 could be a useful strategy to treat several types of cancer. To discover small-molecule inhibitors of the bromodomain of ATAD2, we used a fragment-based approach. Fragment hits were identified using NMR spectroscopy, and ATAD2 was crystallized with three of the hits identified in the fragment screen.

References

16